Total Funding
44
12
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
508070
PluroGen Therapeutics provides clinically advanced and advantaged burn, wound, and skin care products.
Glenn Warden: Chief Medical OfficerPast Role: University of Cincinnati, Professor and Vice Chairman of Surgery
George Rodeheaver: Co-Founder
About the Company
PluroGen's core technology platform was developed by researchers and physicians in University of Virginia's (UVA) Plastic Surgery Research Laboratory beginning in the 1970's. Their co-founder, George T. Rodeheaver, Ph.D., is one of the inventors of this technology and has supervised the formulation and production at UVA of one of
their first products for use on burn and chronic wound patients at the UVA Health System for the past fifteen years.
